| Product Code: ETC12345545 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The import shipments of HCV direct-acting antivirals to Brunei in 2024 saw a continued high concentration of supply from top exporting countries Malaysia, Singapore, Ireland, USA, and Australia. The Herfindahl-Hirschman Index (HHI) indicated a significant increase in market concentration from 2023 to 2024, reaching a very high level. Despite a negative compound annual growth rate (CAGR) of -12.13% from 2020 to 2024, there was a slight improvement in the growth rate from 2023 to 2024 at -5.61%. This suggests a challenging market environment with potential shifts in the competitive landscape.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brunei HCV Direct Acting Antiviral Market Overview |
3.1 Brunei Country Macro Economic Indicators |
3.2 Brunei HCV Direct Acting Antiviral Market Revenues & Volume, 2022 & 2032F |
3.3 Brunei HCV Direct Acting Antiviral Market - Industry Life Cycle |
3.4 Brunei HCV Direct Acting Antiviral Market - Porter's Five Forces |
3.5 Brunei HCV Direct Acting Antiviral Market Revenues & Volume Share, By Product Type, 2022 & 2032F |
3.6 Brunei HCV Direct Acting Antiviral Market Revenues & Volume Share, By Drug Class, 2022 & 2032F |
3.7 Brunei HCV Direct Acting Antiviral Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 Brunei HCV Direct Acting Antiviral Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Brunei HCV Direct Acting Antiviral Market Trends |
6 Brunei HCV Direct Acting Antiviral Market, By Types |
6.1 Brunei HCV Direct Acting Antiviral Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Brunei HCV Direct Acting Antiviral Market Revenues & Volume, By Product Type, 2022 - 2032F |
6.1.3 Brunei HCV Direct Acting Antiviral Market Revenues & Volume, By HCV Antibody, 2022 - 2032F |
6.1.4 Brunei HCV Direct Acting Antiviral Market Revenues & Volume, By HCV Viral Load, 2022 - 2032F |
6.1.5 Brunei HCV Direct Acting Antiviral Market Revenues & Volume, By HCV Genotyping, 2022 - 2032F |
6.2 Brunei HCV Direct Acting Antiviral Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Brunei HCV Direct Acting Antiviral Market Revenues & Volume, By NS3/4A Protease Inhibitors, 2022 - 2032F |
6.2.3 Brunei HCV Direct Acting Antiviral Market Revenues & Volume, By NS5A Polymerase Inhibitors, 2022 - 2032F |
6.2.4 Brunei HCV Direct Acting Antiviral Market Revenues & Volume, By NS5B Polymerase Inhibitors, 2022 - 2032F |
6.2.5 Brunei HCV Direct Acting Antiviral Market Revenues & Volume, By Combination Drugs, 2022 - 2032F |
6.3 Brunei HCV Direct Acting Antiviral Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Brunei HCV Direct Acting Antiviral Market Revenues & Volume, By Hospital Pharmacy, 2022 - 2032F |
6.3.3 Brunei HCV Direct Acting Antiviral Market Revenues & Volume, By Online Pharmacy, 2022 - 2032F |
6.3.4 Brunei HCV Direct Acting Antiviral Market Revenues & Volume, By Retail Pharmacy, 2022 - 2032F |
7 Brunei HCV Direct Acting Antiviral Market Import-Export Trade Statistics |
7.1 Brunei HCV Direct Acting Antiviral Market Export to Major Countries |
7.2 Brunei HCV Direct Acting Antiviral Market Imports from Major Countries |
8 Brunei HCV Direct Acting Antiviral Market Key Performance Indicators |
9 Brunei HCV Direct Acting Antiviral Market - Opportunity Assessment |
9.1 Brunei HCV Direct Acting Antiviral Market Opportunity Assessment, By Product Type, 2022 & 2032F |
9.2 Brunei HCV Direct Acting Antiviral Market Opportunity Assessment, By Drug Class, 2022 & 2032F |
9.3 Brunei HCV Direct Acting Antiviral Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 Brunei HCV Direct Acting Antiviral Market - Competitive Landscape |
10.1 Brunei HCV Direct Acting Antiviral Market Revenue Share, By Companies, 2025 |
10.2 Brunei HCV Direct Acting Antiviral Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here